Evidence-Based Treatment of Severe Psoriasis by Individualised Homoeopathy: Case Reports

Abstract

Psoriasis is a chronic skin disease with manifestations in skin, nails and joints. The disease usually runs a long course of remission and relapses, and is usually worse in winters. Psoriasis Area and Severity Index (PASI) score above 15 is considered to be an independent criterion for classifying a case as severe psoriasis. The conventional systemic therapy controls the symptoms but is costly and has known adverse effects. Individualised homoeopathic treatment has a potential role in providing safe and cost-effective treatment in psoriasis. In this article, three cases of severe psoriasis vulgaris treated with Homoeopathy at Bakson Homoeopathic Medical College and hospital are presented. Two cases were under treatment for a period of 20 months and one case received treatment for 24 months. Significant reduction (60–100%) in PASI score was observed with individualised homoeopathic treatment.

Keywords

psoriasis - homoeopathy - Individualised homoeopathic treatment - repertory - PASI score

Patient Consent

Written informed consent was taken by the patients.

Publikationsverlauf

Artikel online veröffentlicht:
30. September 2022

• References

• 1 Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician 2017; 63 (04) 278-285
• 2 Gupta R, Manchanda RK. Textbook of Dermatology for Homoeopaths. 3rd edition. New Delhi: B. Jain Publishers (P) Ltd, India; 2009: 186-190
• 3 Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010; 76 (06) 595-601
• 4 Eder L, Haddad A, Rosen CF. et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol 2016; 68 (04) 915-923
• 5 Kuchekar AB, Pujari RR, Kuchekar SB. et al. Psoriasis: a comprehensive review. Int J Pharmacy Life Sci 2011; 2: 857-877 http://www.ijplsjournal.com/home.html
• 6 Meneguin S, de Godoy NA, Pollo CF, Miot HA, de Oliveira C. Quality of life of patients living with psoriasis: a qualitative study. BMC Dermatol 2020; 20 (01) 22
• 7 Puzenat E, Bronsard V, Prey S. et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24 (Suppl 2): 10-16
• 8 Carlin CS, Feldman SR, Krueger JG, Menter A, Krueger GGA. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol 2004; 50 (06) 859-866
• 9 Llamas-Velasco M, de la Cueva P, Notario J, Martínez-Pilar L, Martorell A, Moreno-Ramírez D. Moderate psoriasis: a proposed definition. Actas Dermosifiliogr 2017; 108 (10) 911-917 . web link: es-linkresolver-psoriasis-moderada-propuesta-definicion-S0001731017303769
• 10 Dutta S, Chawla S, Kumar S. Psoriasis: a review of existing therapies and recent advances in treatment. J Rational Pharmacotherapeutic Res 2018; 4 (01) 12-23
• 11 Ramanunny AK, Wadhwa S, Singh SK, Sharma DS, Khursheed R, Awasthi A. Treatment strategies against psoriasis: principle, perspectives and practices. Curr Drug Deliv 2020; 17 (01) 52-73
• 12 Gottlieb AB. Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov 2005; 4 (01) 19-34
• 13 Hahnemann S. Organon of Medicine. 5 ^th & 6 ^th edition, New Delhi: B Jain Publishers (P) Ltd; 1970
• 14 Allen HC. Keynotes and Characteristics with Comparisons of some of the Leading Remedies of the Materia Medica, Reprint Edition. Kolkata: Medical Book Publishers; 2002: 279
• 15 Nwabudike LC. Palmar and plantar psoriasis and homeopathy – case reports. Our Dermatol Online. 2017; 8 (01) 66-69 http://www.odermatol.com
• 16 Rahman S, Dey J. A case report of plantar psoriasis treated with homoeopathy. Homoeopathic Links 2018; 31 (04) 248-253
• 17 Ram H, Kamboj M. Effect of individualized homoeopathic medicine in psoriasis: a case report. National Homoeo Recorder 2019; 15 (02) 41-46